Literature DB >> 18452421

Comparison of type a botulinum toxin products in clinical use.

A Pickett, D Caird.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18452421     DOI: 10.1111/j.1365-2710.2008.00904.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


× No keyword cloud information.
  4 in total

1.  Consistent biochemical data are essential for comparability of botulinum toxin type A products.

Authors:  Andy Pickett
Journal:  Drugs R D       Date:  2011

2.  Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data.

Authors:  Andy Pickett
Journal:  Clin Ophthalmol       Date:  2011-09-09

3.  Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.

Authors:  Ramtin Kassir; Aparanjita Kolluru; Martin Kassir
Journal:  Dermatol Ther (Heidelb)       Date:  2013-08-16

4.  Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation.

Authors:  Andy Pickett
Journal:  Clin Pharmacol       Date:  2013-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.